A detailed history of Westend Capital Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Westend Capital Management, LLC holds 463 shares of OGN stock, worth $6,755. This represents 0.0% of its overall portfolio holdings.

Number of Shares
463
Previous 463 -0.0%
Holding current value
$6,755
Previous $9.4 Million 5.82%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$13.78 - $18.8 $6,380 - $8,704
463 New
463 $8.7 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Westend Capital Management, LLC Portfolio

Follow Westend Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westend Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westend Capital Management, LLC with notifications on news.